Get started
Author

Anitha Krishnan

Observed names: A. Krishnan, Anitha G. Krishnan
ORCID: 0000-0001-9581-7125
Observed ORCID: 0000-0001-9581-7125
OpenAlex ID: A5080955790
Reprogramming to recover youthful epigenetic information and restore vision
2020 · Yuancheng Lu, Benedikt Brommer, et al. · Nature · 816
Soluble CD163 Made by Monocyte/Macrophages Is a Novel Marker of HIV Activity in Early and Chronic Infection Prior to and After Anti-retroviral Therapy
2011 · Tricia H. Burdo, Margaret R. Lentz, et al. · The Journal of Infectious Diseases · 336
PDF
Increased Monocyte Turnover from Bone Marrow Correlates with Severity of SIV Encephalitis and CD163 Levels in Plasma
2010 · Tricia H. Burdo, Caroline Soulas, et al. · PLoS Pathogens · 195
PDF
A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
2019 · Anitha Krishnan, Andrew J. Kocab, et al. · Journal of Neuroinflammation · 136
PDF
Chronic Morphine Administration Delays Wound Healing by Inhibiting Immune Cell Recruitment to the Wound Site
2009 · Josephine L. Martin, Lisa Koodie, et al. · American Journal Of Pathology · 132
PDF
Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma
2016 · Anitha Krishnan, Fei Fei, et al. · The Journal of Immunology · 66
PDF
Morphine induced exacerbation of sepsis is mediated by tempering endotoxin tolerance through modulation of miR-146a
2013 · Santanu Banerjee, Jingjing Meng, et al. · Scientific Reports · 63
PDF
Morphine Modulation of Toll-Like Receptors in Microglial Cells Potentiates Neuropathogenesis in a HIV-1 Model of Coinfection with Pneumococcal Pneumoniae
2012 · R. Dutta, A. Krishnan, et al. · Journal of Neuroscience · 42
PDF
Mouse model of ocular hypertension with retinal ganglion cell degeneration
2019 · Ryo Mukai, Dong Ho Park, et al. · PLoS ONE · 35
PDF
Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma
2023 · Margarete M. Karg, Yuancheng Ryan Lu, et al. · Cellular Reprogramming · 34
PDF
PolySialic acid-nanoparticles inhibit macrophage mediated inflammation through Siglec agonism: a potential treatment for age related macular degeneration
2023 · Anitha Krishnan, Victor G. Sendra, et al. · Frontiers in Immunology · 27
Reversal of ageing- and injury-induced vision loss by Tet-dependent epigenetic reprogramming
2019 · Yuancheng Lu, Anitha Krishnan, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 20
PDF
Morphine Withdrawal Inhibits IL-12 Induction in a Macrophage Cell Line through a Mechanism That Involves cAMP
2008 · Jennifer Kelschenbach, Jana Ninkovic, et al. · The Journal of Immunology · 16
PDF
PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration
2024 · Sheri L. Peterson, Anitha Krishnan, et al. · Pharmaceuticals · 13
PDF
Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials
2024 · Anitha Krishnan, David G. Callanan, et al. · Pharmaceuticals · 12
PDF
Sialic Acid Mimetic Microglial Sialic Acid-Binding Immunoglobulin-like Lectin Agonism: Potential to Restore Retinal Homeostasis and Regain Visual Function in Age-Related Macular Degeneration
2023 · Michael J. Tolentino, Andrew J. Tolentino, et al. · Pharmaceuticals · 8
Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity
2024 · Husam Nawafleh, Nagwa Zeinelabdin, et al. · Pharmaceuticals · 4
PDF
Destructive neuroinflammation triggered by activation of the NLRP3 inflammasome in the glaucomatous optic nerve head
2017 · Meredith Gregory‐Ksander, Fei Fei, et al. · Investigative Ophthalmology & Visual Science · 3
Gene therapy treatment with AAV-soluble Fas ligand protects retinal ganglion cells during development of Glaucoma
2015 · Anitha Krishnan, Fei Fei, et al. · Investigative Ophthalmology & Visual Science · 3
Pharmacologic inhibition of the NLRP3 inflammasome - a novel neuroprotective therapy for glaucoma
2019 · Anitha Krishnan, Malvika Dua, et al. · Investigative Ophthalmology & Visual Science · 2
Soluble Fas ligand provides long-term protection in a chronic mouse model of glaucoma by inhibiting glial activation, inflammation, and apoptosis
2016 · Meredith Gregory‐Ksander, Fei Fei, et al. · Investigative Ophthalmology & Visual Science · 2
Preventing glaucoma by blocking activation of the NLRP3 inflammasome in the optic nerve head
2015 · Fei Fei, Anitha Krishnan, et al. · Investigative Ophthalmology & Visual Science · 1
Intravitreal administration of AAV2.soluble Fas ligand gene therapy following glaucoma injury restores retinal ganglion cell function and stops disease progression
2020 · Meredith Gregory‐Ksander, Maleeka Shrestha, et al. · Investigative Ophthalmology & Visual Science
InflaMab: A novel NLRP3 Inflammasome inhibitor provides neuroprotection in a mouse model of glaucoma
2020 · Melody Chemaly, Anitha Krishnan, et al. · Investigative Ophthalmology & Visual Science
Fas signaling triggers glial-mediated neuroinflammation in glaucoma
2019 · Meredith Gregory‐Ksander, Wennan Lu, et al. · Investigative Ophthalmology & Visual Science
Works count: 27
Citation count: 1,965
H-index: 13
I10-index: 15
Year
Topic
Type